Total Payments
$584,671
2024 Payments
$24,735
Companies
29
Transactions
932
Medicare Patients
3,067
Medicare Billing
$400,555
Payment Breakdown by Category
Other$413,304 (70.7%)
Travel$88,769 (15.2%)
Consulting$62,916 (10.8%)
Food & Beverage$19,294 (3.3%)
Research$220.00 (0.0%)
Education$167.42 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $352,584 | 138 | 60.3% |
| Travel and Lodging | $88,769 | 314 | 15.2% |
| Consulting Fee | $62,916 | 21 | 10.8% |
| Honoraria | $60,720 | 29 | 10.4% |
| Food and Beverage | $19,294 | 425 | 3.3% |
| Unspecified | $220.00 | 1 | 0.0% |
| Education | $167.42 | 4 | 0.0% |
Payments by Type
General
$584,451
931 transactions
Research
$220.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| US WorldMeds, LLC | $170,395 | 326 | $0 (2020) |
| MDD US Operations, LLC | $138,434 | 133 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $97,625 | 117 | $0 (2024) |
| Adamas Pharmaceuticals, Inc. | $39,431 | 55 | $0 (2021) |
| Allergan, Inc. | $31,756 | 62 | $0 (2020) |
| Lundbeck LLC | $29,387 | 45 | $0 (2019) |
| Ipsen Biopharmaceuticals, Inc | $26,086 | 43 | $0 (2019) |
| UCB, Inc. | $22,278 | 34 | $0 (2020) |
| Kyowa Kirin, Inc. | $6,735 | 8 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $5,613 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24,735 | 35 | MDD US Operations, LLC ($24,713) |
| 2023 | $46,496 | 48 | MDD US Operations, LLC ($35,656) |
| 2022 | $52,178 | 59 | MDD US Operations, LLC ($49,297) |
| 2021 | $31,450 | 23 | MDD US Operations, LLC ($28,768) |
| 2020 | $12,248 | 31 | ACADIA Pharmaceuticals Inc ($7,058) |
| 2019 | $118,806 | 211 | US WorldMeds, LLC ($40,877) |
| 2018 | $158,601 | 300 | US WorldMeds, LLC ($65,036) |
| 2017 | $140,156 | 225 | US WorldMeds, LLC ($63,982) |
All Payment Transactions
932 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2024 | MDD US Operations, LLC | Gocovri (Drug) | Consulting Fee | Cash or cash equivalent | $3,125.00 | General |
| Category: AMANTADINE | ||||||
| 09/27/2024 | MDD US Operations, LLC | Gocovri (Drug) | Travel and Lodging | In-kind items and services | $742.40 | General |
| Category: AMANTADINE | ||||||
| 09/27/2024 | MDD US Operations, LLC | Gocovri (Drug) | Travel and Lodging | In-kind items and services | $736.95 | General |
| Category: AMANTADINE | ||||||
| 09/27/2024 | MDD US Operations, LLC | Gocovri (Drug) | Travel and Lodging | In-kind items and services | $192.00 | General |
| Category: AMANTADINE | ||||||
| 09/27/2024 | MDD US Operations, LLC | Gocovri (Drug) | Travel and Lodging | In-kind items and services | $132.10 | General |
| Category: AMANTADINE | ||||||
| 09/27/2024 | MDD US Operations, LLC | Gocovri (Drug) | Travel and Lodging | In-kind items and services | $115.50 | General |
| Category: AMANTADINE | ||||||
| 09/27/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $61.46 | General |
| Category: AMANTADINE | ||||||
| 09/27/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $57.72 | General |
| Category: AMANTADINE | ||||||
| 09/27/2024 | MDD US Operations, LLC | Gocovri (Drug) | Travel and Lodging | In-kind items and services | $48.00 | General |
| Category: AMANTADINE | ||||||
| 09/27/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $45.90 | General |
| Category: AMANTADINE | ||||||
| 09/27/2024 | MDD US Operations, LLC | Gocovri (Drug) | Travel and Lodging | In-kind items and services | $40.20 | General |
| Category: AMANTADINE | ||||||
| 09/27/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $35.61 | General |
| Category: AMANTADINE | ||||||
| 09/27/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $32.40 | General |
| Category: AMANTADINE | ||||||
| 06/21/2024 | MDD US Operations, LLC | Gocovri (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,060.00 | General |
| Category: AMANTADINE | ||||||
| 06/21/2024 | MDD US Operations, LLC | Gocovri (Drug) | Travel and Lodging | In-kind items and services | $588.74 | General |
| Category: AMANTADINE | ||||||
| 06/21/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $38.13 | General |
| Category: AMANTADINE | ||||||
| 04/05/2024 | MDD US Operations, LLC | Apokyn (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,210.00 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 04/01/2024 | MDD US Operations, LLC | Apokyn (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,420.00 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 04/01/2024 | MDD US Operations, LLC | Apokyn (Drug) | Travel and Lodging | In-kind items and services | $980.32 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 04/01/2024 | MDD US Operations, LLC | Apokyn (Drug) | Travel and Lodging | In-kind items and services | $661.05 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 04/01/2024 | MDD US Operations, LLC | Apokyn (Drug) | Travel and Lodging | In-kind items and services | $272.01 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 04/01/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $58.72 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 04/01/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $35.49 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 04/01/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 04/01/2024 | MDD US Operations, LLC | Apokyn (Drug) | Travel and Lodging | In-kind items and services | $1.99 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| EFFECT OF LY3154207 ON COGNITION IN MILD TO MODERATE PARKINSONS DISEASE DEMENTIA PDD - THE PRESENCE STUDY | Eli Lilly and Company | $220.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 693 | 1,319 | $648,912 | $94,071 |
| 2022 | 13 | 753 | 1,475 | $687,311 | $95,310 |
| 2021 | 20 | 910 | 1,748 | $757,664 | $121,468 |
| 2020 | 14 | 711 | 1,333 | $564,096 | $89,706 |
Total Patients
3,067
Total Services
5,875
Medicare Billing
$400,555
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 74 | 195 | $183,057 | $23,254 | 12.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 112 | 163 | $113,937 | $17,832 | 15.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 106 | 125 | $62,750 | $8,901 | 14.2% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2023 | 37 | 95 | $61,845 | $6,842 | 11.1% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 25 | 48 | $53,549 | $6,429 | 12.0% |
| 64645 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, each additional extremity | Office | 2023 | 27 | 74 | $32,634 | $4,641 | 14.2% |
| 64611 | Injection of chemical for paralysis of salivary glands on both sides of mouth | Office | 2023 | 22 | 53 | $23,638 | $4,615 | 19.5% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 19 | 45 | $24,986 | $4,342 | 17.4% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 112 | 268 | $20,904 | $4,155 | 19.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $18,744 | $3,234 | 17.3% |
| 95984 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | Office | 2023 | 40 | 97 | $16,102 | $3,102 | 19.3% |
| 95983 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, first 15 minutes with qualified health professional | Office | 2023 | 41 | 67 | $12,663 | $2,409 | 19.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 25 | $7,001 | $1,646 | 23.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $7,190 | $1,513 | 21.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 28 | $9,912 | $1,157 | 11.7% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 76 | 211 | $198,513 | $23,304 | 11.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 164 | 220 | $106,792 | $14,788 | 13.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 81 | 108 | $72,959 | $11,321 | 15.5% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2022 | 47 | 107 | $69,657 | $7,907 | 11.4% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 22 | 48 | $48,418 | $5,814 | 12.0% |
| 64645 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, each additional extremity | Office | 2022 | 33 | 85 | $37,485 | $5,370 | 14.3% |
| 64611 | Injection of chemical for paralysis of salivary glands on both sides of mouth | Office | 2022 | 22 | 62 | $27,652 | $4,859 | 17.6% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 18 | 49 | $26,607 | $4,686 | 17.6% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 119 | 299 | $22,562 | $4,404 | 19.5% |
| 95984 | Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator with brain stimulator programming, each additional 15 minutes with qualified health professional | Office | 2022 | 46 | 116 | $19,256 | $3,858 | 20.0% |
About Lin Zhang
Lin Zhang is a Neurology healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1245215946.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lin Zhang has received a total of $584,671 in payments from pharmaceutical and medical device companies, with $24,735 received in 2024. These payments were reported across 932 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($352,584).
As a Medicare-enrolled provider, Zhang has provided services to 3,067 Medicare beneficiaries, totaling 5,875 services with total Medicare billing of $400,555. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Sacramento, CA
- Active Since 12/14/2005
- Last Updated 07/08/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1245215946
Products in Payments
- APOKYN (Drug) $124,172
- NUPLAZID (Drug) $97,625
- GOCOVRI (Drug) $93,958
- Xadago (Drug) $74,147
- NORTHERA (Drug) $29,387
- Neupro (Drug) $22,278
- BOTOX (Biological) $21,655
- MYOBLOC (Biological) $21,630
- Apokyn (Drug) $15,661
- DYSPORT (Drug) $11,724
- BOTOX (Drug) $9,917
- Gocovri (Drug) $9,052
- Dysport 300 U-1 (Drug) $7,816
- NOURIANZ (Drug) $6,735
- Dysport (Drug) $6,546
- INGREZZA (Drug) $5,613
- Duopa (Drug) $4,448
- CUVRIOR (Drug) $4,131
- INBRIJA (Drug) $814.51
- AJOVY (Drug) $264.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Sacramento
Michael Chez, Md, MD
Neurology — Payments: $477,357
Neurology $477,357
Dr. Michael Rogawski, M.d, M.D
Neurology — Payments: $214,540
Neurology $214,540
Dr. Yelena Usmanova, Md, MD
Neurology — Payments: $130,744
Neurology $130,744
Charles Decarli, Md, MD
Neurology — Payments: $127,304
Neurology $127,304
Maria Noelle Florendo, Md, MD
Neurology — Payments: $40,000
Neurology $40,000
Jack Lin, Md, MD
Neurology — Payments: $39,047
Neurology $39,047